Results 271 to 273 of about 186,761 (273)

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

Lancet, The
Domenica Lorusso, Kosei Hasegawa, Ekkasit Tharavichitkul   +2 more
exaly  

Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial

Annals of Oncology
Hiroshige Yoshioka, Toshiaki Takahashi
exaly  

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study

Lancet, The
exaly